Nynke F Kalkers
Overview
Explore the profile of Nynke F Kalkers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coerver E, Fung W, de Beukelaar J, Bouvy W, Canta L, Gerlach O, et al.
JAMA Neurol
. 2024 Dec;
82(2):123-131.
PMID: 39652340
Importance: Increasing numbers of people with multiple sclerosis (MS) use disease-modifying therapy (DMT). Long-term stable disease while taking such medications provides a rationale for considering DMT discontinuation given patient burden,...
2.
Toorop A, Wessels M, Boonkamp L, Gelissen L, Hoitsma E, Zeinstra E, et al.
Mult Scler
. 2024 Nov;
30(13):1683-1688.
PMID: 39494701
Background: Biomarkers of neuronal and axonal damage (serum neurofilament light (sNfL) and serum glial fibrillary acidic protein (sGFAP)) may provide insight into the aetiology of natalizumab wearing-off symptoms (WoSs). Objectives:...
3.
Toorop A, van Lierop Z, Gelissen L, Hoitsma E, Zeinstra E, van Rooij L, et al.
J Neurol Neurosurg Psychiatry
. 2023 Nov;
95(5):392-400.
PMID: 37963723
Background: Extended interval dosing (EID) of natalizumab is a promising strategy to optimise treatment in multiple sclerosis (MS). Personalised EID by therapeutic drug monitoring can enable further extension of treatment...
4.
van Kempen Z, Hoogervorst E, Wattjes M, Kalkers N, Mostert J, Lissenberg-Witte B, et al.
Neurology
. 2020 Jul;
95(6):e745-e754.
PMID: 32690785
Objective: To determine whether natalizumab efficacy is maintained when switching to personalized extended interval dosing based on individual natalizumab trough concentrations in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: This...
5.
Kalkers N, Galan I, Kerbrat A, Tacchino A, Kamm C, OConnell K, et al.
Mult Scler
. 2019 Dec;
27(1):90-96.
PMID: 31845614
Background: The Arm function in Multiple Sclerosis Questionnaire (AMSQ) has been developed as a self-reported measure of arm and hand functioning for patients with multiple sclerosis (MS). The AMSQ was...
6.
van Munster C, Kaya L, Obura M, Kalkers N, Uitdehaag B
Mult Scler
. 2019 Jan;
26(4):505-508.
PMID: 30657002
Background: The Arm Function in Multiple Sclerosis Questionnaire (AMSQ) has been developed to assess upper extremity function of patients with multiple sclerosis (MS). A minimal clinically important difference (MCID) value...
7.
Ruiter A, Meilof J, Somanje-Bolweg R, van Gorsel E, Kalkers N
Case Rep Neurol
. 2017 Apr;
9(1):12-16.
PMID: 28413400
We present the unusual case of a patient with an aquaporin 4 antibody-seropositive neuromyelitis optica spectrum disorder who presented with autonomic dysregulation, cognitive impairment, and symptoms of psychosis. Only a...
8.
Jasperse B, Minneboo A, de Groot V, Kalkers N, van Helden P, Uitdehaag B, et al.
Arch Neurol
. 2007 Feb;
64(2):190-4.
PMID: 17296834
Objective: To identify determinants visible on magnetic resonance imaging of the brain that explain the subsequent rate of cerebral atrophy in patients with recently diagnosed multiple sclerosis. Design: Magnetic resonance...
9.
Huijbregts S, Kalkers N, de Sonneville L, de Groot V, Polman C
J Neurol Sci
. 2006 Apr;
245(1-2):187-94.
PMID: 16643951
This paper presents results of two studies conducted to investigate cognition in different MS subtypes. First, the results of a study that has previously been published will be discussed. This...
10.
Killestein J, Kalkers N, Polman C
J Neurol Sci
. 2005 Jun;
233(1-2):113-5.
PMID: 15949499
In addition to demyelination and damage to oligodendrocytes, axonal injury and neuronal cell death are dominating histopathological characteristics of multiple sclerosis (MS). Still little is known about the cause of...